跳到主要內容

臺灣博碩士論文加值系統

(3.215.79.68) 您好!臺灣時間:2022/07/04 04:47
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

我願授權國圖
: 
twitterline
研究生:許家誠
研究生(外文):Chia-Cheng Hsu
論文名稱:樟芝子實體乙醇萃取物對原發性腫瘤微環境中與發炎相關生物指標之影響
論文名稱(外文):Effects of Ethanol Extract Derived from Fruit-Body of Antrodia cinnamomea on Inflammation-related Biomarkers in Primary Tumor Microenvironment
指導教授:陳秀男陳秀男引用關係
口試委員:冉繁華劉秉忠古鎮鈞陳哲俊王俊順黃世鈴
口試日期:2014-07-25
學位類別:碩士
校院名稱:國立臺灣大學
系所名稱:漁業科學研究所
學門:農業科學學門
學類:漁業學類
論文種類:學術論文
論文出版年:2014
畢業學年度:102
語文別:中文
論文頁數:79
中文關鍵詞:樟芝樟芝子實體乙醇萃取物腫瘤微環境發炎反應細胞激素
外文關鍵詞:Antrodia cinnamomeaethanol extract of fruiting body of Antrodia cinnamomea (EEAC)tumor microenvironmentinflammationcytokines
相關次數:
  • 被引用被引用:0
  • 點閱點閱:351
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
發炎反應在腫瘤發展的不同階段扮演著舉足輕重的角色,包含腫瘤形成、增殖、惡化、侵蝕與轉移。發炎性的環境對於腫瘤的進展具有深遠的影響。當改變腫瘤微環境中與發炎相關之因子之表現量時能調控腫瘤的生長。本研究利用乙醇萃取樟芝子實體,觀察以口服灌食和塗抹方式來探討給予擔癌小鼠樟芝萃取物後,血清及腫瘤微環境中與發炎相關細胞激素、生長因子以及原發性腫瘤生長之影響。

結果顯示,樟芝乙醇萃取物可降低小鼠肺癌細胞株(Lewis Lung Carcinoma)之活性,LLC活性的抑制有濃度依賴關係。口服灌食8 mg/kg 體重劑量樟芝萃取物可降低擔癌小鼠血清中COX-2及VEGF含量,並降低擔癌小鼠原發位腫瘤微環境中IL-1β、TNF-α、IL-6、COX-2、PTGER2與VEGF等發炎相關因子之基因表現量,並且減緩小鼠大腿原發位腫瘤的體積與重量生長。同時,口服樟芝乙醇萃取物搭配塗抹樟芝三&;#33820;類萃取物對原發性腫瘤的抑制、血清與腫瘤微環境中發炎相關因子與單純口服樟芝萃取物並未發現有顯著性的差異。

總括上述,樟芝萃取物降低了小鼠肺癌細胞株之活性、降低擔癌小鼠血清與腫瘤微環境中發炎相關因子的表現量,以及減緩原發性腫瘤的生長。未來在癌症治療應用方面,樟芝萃取物可能具有輔助性治療的潛力。


Inflammatory responses play decisive roles at different stages of tumor development, including initiation, promotion, malignant conversion, invasion, and metastasis. Inflammation in the tumor microenvironment induces many tumor-promoting effects. The present study is to investigate the effect of oral administration and skin smear of ethanol extract of fruit body of Antrodia cinnamomea (EEAC) on inflammation-related cytokines and growth factors in the primary tumor microenvironment.

The results showed that EEAC treatment dose-dependently reduced LLC cell viability. For LLC tumor model, oral administration 8 mg/kg of body weight of EEAC significantly reduced COX-2 and VEGF production in serum. In addition, IL-1β、TNF-α、IL-6、COX-2、PTGER2 and VEGF mRNA expression were substantially declined within the tumor microenvironment after oral EEAC treatment, and the primary tumor was significantly suppressed. However, oral administration and skin smear of EEAC showed no significant variation neither in tumor growth nor inflammation-related factor expression in serum and the tumor microenvironment between the treated mice.

To sum up, EEAC reduced LLC cell viability, COX-2 and VEGF production in serum, and inflammation-related mRNA expression declined within the tumor microenvironment. Results obtained from the present study may suggest that EEAC may possess a potentiality for cancer chemotherapeutic activity.


中文摘要 ……………………………………………………………Ⅰ
英文摘要 ……………………………………………………………Ⅱ
目錄 …………………………………………………………………Ⅲ
圖表附件目錄………………………………………………………Ⅳ
第一章 前言…………………………………………………………1
第二章 文獻整理……………………………………………………3
第三章 材料與方法…………………………………………………15
第四章 結果…………………………………………………………28
第五章 討論…………………………………………………………35
第六章 結論…………………………………………………………43
參考文獻…………………………………………………………………44
圖表附件…………………………………………………………………61


參考文獻
王婉媜 (2013). 菇蕈多醣體對於原發位腫瘤為環境之影響 (國立台灣大學漁業科學研究所碩士論文).

行政院衛生福利部統計處 (2014). 中華民國102年國人主要死因統計結果.

張中懷 (2014). 樟芝子實體乙醇萃取物對肺腺癌擔癌小鼠細胞轉移之影響 (國立台灣大學漁業科學研究所碩士論文).

陳甫安, 徐大為, 王緯書 (2010). 血管內皮生長因子的表現量與腎臟疾病的關聯性. 內科學誌 21, 337-343.

陳健棋 (2000). 食品菇類在醫藥上的應用. 食品工業月刊 32, 54-66.

廖繼鼎 (2010). 臨床腫瘤學 (合記圖書出版社).

Aggarwal, B., and Aggarwal (2003). Signalling pathways of the TNF superfamily: a double-edged sword. Nature reviews Immunology 3, 745-756.

Aggarwal, B.B., Shishodia, S., Sandur, S.K., Pandey, M.K., and Sethi, G. (2006). Inflammation and cancer: how hot is the link? Biochemical pharmacology 72, 1605-1621.

Akira, S., Akira, K., Takeda, T., and Kaisho (2001). Toll-like receptors: critical proteins linking innate and acquired immunity. Nature immunology 2, 675-680.

Altorki, N.K., Keresztes, R.S., Port, J.L., Libby, D.M., Korst, R.J., Flieder, D.B., Ferrara, C.A., Yankelevitz, D.F., Subbaramaiah, K., Pasmantier, M.W., et al. (2003). Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer. Journal of clinical oncology 21, 2645-2650.

Apte, R.N., and Voronov, E. (2002). Interleukin-1--a major pleiotropic cytokine in tumor-host interactions. Seminars in cancer biology 12, 277-290.

Ariztia, E., Ariztia, C., Lee, R., Gogoi, D., and Fishman (2006). The tumor microenvironment: key to early detection. Critical reviews in clinical laboratory Sciences 43, 393-425.

Arlt, A., Vorndamm, J., Muerkoster, S., Yu, H., Schmidt, W.E., Folsch, U.R., and Schafer, H. (2002). Autocrine Production of Interleukin 1β Confers Constitutive Nuclear Factor κB Activity and Chemoresistance in Pancreatic Carcinoma Cell Lines. Cancer research 62, 910-916.

Arnott, C., Arnott, K., Scott, R., Moore, S., Robinson, R., Thompson, F., and Balkwill (2004). Expression of both TNF-α receptor subtypes is essential for optimal skin tumour development. Oncogene 23, 1902-1910.

Balkwill, F. (2009). Tumour necrosis factor and cancer. Nature Reviews Cancer 9, 361-371.

Balkwill, F., and Mantovani, A. (2001). Inflammation and cancer: back to Virchow? Lancet 357, 539-545.

Bani, M.R., Garofalo, A., Scanziani, E., and Giavazzi, R. (1991). Effect of interleukin-1-beta on metastasis formation in different tumor systems. Journal of the National Cancer Institute and Journal of the National Cancer Institute Monographs 83, 119-123.

Baronzio, G., Fiorentini, G., and Cogle, C.R. (2009). Cancer Microenvironment and Therapeutic Implications (Springer).

Barry, M., and Bleackley, R.C. (2002). Cytotoxic T lymphocytes: all roads lead to death. Nature reviews Immunology 2, 401-409.

Beatty, G.L., Chiorean, E.G., Fishman, M.P., Saboury, B., Teitelbaum, U.R., Sun, W., Huhn, R.D., Song, W., Li, D., Sharp, L.L., et al. (2011). CD40 Agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science (New York, NY) 331, 1612-1616.

Bennett, A. (1986). The production of prostanoids in human cancers, and their implications for tumor progression. Progress in lipid research 25, 539-542.

Breyer, R.M., Bagdassarian, C.K., Myers, S.A., and Breyer, M.D. (2001). Prostanoid receptors: subtypes and signaling. Annual review of pharmacology and toxicology 41, 661-690.

Bu, X., Zhao, C., and Dai, X. (2011). Involvement of COX-2/PGE(2) Pathway in the Upregulation of MMP-9 Expression in Pancreatic Cancer. Gastroenterology research and practice 2011, 214269.

Buckstein, R., Kerbel, R., Shaked, Y., Nayar, R., Foden, C., Turner, R., Lee, C., Taylor, D., Zhang, L., Man, S., et al. (2006). High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin''s lymphoma. Clinical cancer research 12, 5190-5198.

Burke, F., Burke, M., Relf, R., Negus, F., and Balkwill (1996). A cytokine profile of normal and malignant ovary. Cytokine 8, 578-585.

Camphausen, K., Moses, M.A., Beecken, W.D., Khan, M.K., Folkman, J., and O''Reilly, M.S. (2001). Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer research 61, 2207-2211.

Chan, G., Boyle, J.O., Yang, E.K., Zhang, F., Sacks, P.G., Shah, J.P., Edelstein, D., Soslow, R.A., Koki, A.T., Woerner, B.M., et al. (1999). Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer research 59, 991-994.

Chang, S.-T. (1999). Global Impact of Edible and Medicinal Mushrooms on Human Welfare in the 21st Century: Nongreen Revolution. 1, 1-7.

Chang, T.T., and Chou, W.N. (1995). Antrodia cinnamomea sp. nov. on Cinnamomum kanehirai in Taiwan. Mycological Research 99, 756-758.

Chen, C.-H., Yang, S.-W., and Shen, Y.-C. (1995). New Steroid Acids from Antrodia cinnamomea, a Fungal Parasite of Cinnamomum micranthum. Journal of Natural Products 58, 1655-1661.

Chen, Y.Y., Chou, P.Y., Chien, Y.C., Wu, C.H., Wu, T.S., and Sheu, M.J. (2012). Ethanol extracts of fruiting bodies of Antrodia cinnamomea exhibit anti-migration action in human adenocarcinoma CL1-0 cells through the MAPK and PI3K/AKT signaling pathways. Phytomedicine : international journal of phytotherapy and phytopharmacology 19, 768-778.

Cheng, J.J., Huang, N.K., Chang, T.T., Wang, D.L., and Lu, M.K. (2005). Study for anti-angiogenic activities of polysaccharides isolated from Antrodia cinnamomea in endothelial cells. Life sciences 76, 3029-3042.

Cherng, I.H., Wu, D.-P., and Chiang, H.-C. (1996). Triterpenoids from Antrodia cinnamomea. Phytochemistry 41, 263-267.

Chien-Yu, C., Ming-Yong, L., and Tzu-Ming, P. (2005). Determination of Adenosine, Cordycepin and Ergosterol Contents in Cultivated Antrodia camphorata by HPLC Method. Journal of Food and Drug Analysis 13, 338-342.

Chung, Y.C., and Chang, Y.F. (2003). Serum interleukin-6 levels reflect the disease status of colorectal cancer. Journal of surgical oncology 83, 222-226.

Coussens, L.M., and Werb, Z. (2002). Inflammation and cancer. Nature 420, 860-867.

Cozen, W., Gill, P., Ingles, S., Masood, R., MartA&;#402;nez-Maza, O., Cockburn, M., Gauderman, W.J., Pike, M., Bernstein, L., Nathwani, B., et al. (2004). IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma. Blood 103, 3216-3221.

Croci, D.O., Zacarias Fluck, M.F., Rico, M.J., Matar, P., Rabinovich, G.A., and Scharovsky, O.G. (2007). Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment. Cancer immunology, immunotherapy : CII 56, 1687-1700.

Dang, C., Dannenberg, A., Subbaramaiah, K., Dickler, M., Moasser, M., Seidman, A., D''Andrea, G., Theodoulou, M., Panageas, K., Norton, L. (2004). Phase II study of celecoxib and trastuzumab in metastatic breast cancer patients who have progressed after prior trastuzumab-based treatments. Clinical cancer research 10, 4062-4067.

DeNardo, D.G., and Coussens, L.M. (2007). Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast cancer research : BCR 9, 212.

Denkert, C., KA&;#402;bel, M., Berger, S., Siegert, A., Leclere, A., Trefzer, U., and Hauptmann, S. (2001). Expression of cyclooxygenase 2 in human malignant melanoma. Cancer research 61, 303-308.

Digel, W., SchA&;#402;niger, W., Stefanic, M., Janssen, H., Buck, C., Schmid, M., Raghavachar, A., and Porzsolt, F. (1990). Receptors for tumor necrosis factor on neoplastic B cells from chronic lymphocytic leukemia are expressed in vitro but not in vivo. Blood 76, 1607-1613.

Digel, W., Stefanic, M., SchA&;#402;niger, W., Buck, C., Raghavachar, A., Frickhofen, N., Heimpel, H., and Porzsolt, F. (1989). Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia. Blood 73, 1242-1246.

Dimberg, J., Samuelsson, A., Hugander, A., and SA&;#402;derkvist, P. (1999). Differential expression of cyclooxygenase 2 in human colorectal cancer. Gut 45, 730-732.

Dinarello, C.A. (1996). Biologic basis for interleukin-1 in disease. Blood 87, 2095-2147.

Ding, Y.B., Shi, R.H., Tong, J.D., Li, X.Y., Zhang, G.X., Xiao, W.M., Yang, J.G., Bao, Y., Wu, J., Yan, Z.G., et al. (2005). PGE2 up-regulates vascular endothelial growth factor expression in MKN28 gastric cancer cells via epidermal growth factor receptor signaling system. Experimental oncology 27, 108-113.

Du, Y.C., Chang, F.R., Wu, T.Y., Hsu, Y.M., El-Shazly, M., Chen, C.F., Sung, P.J., Lin, Y.Y., Lin, Y.H., Wu, Y.C., et al. (2012). Antileukemia component, dehydroeburicoic acid from Antrodia camphorata induces DNA damage and apoptosis in vitro and in vivo models. Phytomedicine : international journal of phytotherapy and phytopharmacology 19, 788-796.

Dudhgaonkar, S., Thyagarajan, A., and Sliva, D. (2009). Suppression of the inflammatory response by triterpenes isolated from the mushroom Ganoderma lucidum. International immunopharmacology 9, 1272-1280.

Dunn, G.P., Bruce, A.T., Ikeda, H., Old, L.J., and Schreiber, R.D. (2002). Cancer immunoediting: from immunosurveillance to tumor escape. Nature immunology 3, 991-998.

Dunn, G.P., Old, L.J., and Schreiber, R.D. (2004). The three Es of cancer immunoediting. Annual review of immunology 22, 329-360.

Ellis, L.M., Staley, C.A., Liu, W., Fleming, R.Y.D., Parikh, N.U., Bucana, C.D., and Gallick, G.E. (1998). Down-regulation of Vascular Endothelial Growth Factor in a Human Colon Carcinoma Cell Line Transfected with an Antisense Expression Vector Specific for c-src. Journal of Biological Chemistry 273, 1052-1057.

Furstenberger, G., Gross, M., and Marks, F. (1989). Eicosanoids and multistage carcinogenesis in NMRI mouse skin: role of prostaglandins E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion). Carcinogenesis 10, 91-96.

Ferrara, N. (2001). Role of vascular endothelial growth factor in regulation of physiological angiogenesis. American journal of physiology Cell physiology 280, C1358-1366.

Ferrari, V., Valcamonico, F., Amoroso, V., Simoncini, E., Vassalli, L., Marpicati, P., Rangoni, G., Grisanti, S., Tiberio, G.A., Nodari, F. (2006). Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial. Cancer chemotherapy and pharmacology 57, 185-190.

Fidler, I.J., and Ellis, L.M. (1994). The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79, 185-188.

Fisher, D.T., Appenheimer, M.M., and Evans, S.S. (2014). The two faces of IL-6 in the tumor microenvironment. Seminars in Immunology 26, 38-47.

Folkman, J. (1971). Tumor angiogenesis: therapeutic implications. The New England journal of medicine 285, 1182-1186.

Folkman, J. (1986). How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. Cancer research 46, 467-473.

Freedman, R., Deavers, M., Liu, J., and Wang, E. (2004). Peritoneal inflammation - A microenvironment for Epithelial Ovarian Cancer (EOC). Journal of translational medicine 2, 23-23.

Gabrilovich, D.I., and Hurwitz, A.A. (2008). Tumor-Induced Immune Suppression (Springer New York).

Geethangili, M., and Tzeng, Y.-M. (2011). Review of pharmacological effects of Antrodia camphorata and its bioactive compounds. Evidence-Based Complementary and Alternative Medicine 2011: 212641.

Goetzl, E.J., An, S., and Smith, W.L. (1995). Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases. Faseb j 9, 1051-1058.

Gogas, H., Polyzos, A., Stavrinidis, I., Frangia, K., Tsoutsos, D., Panagiotou, P., Markopoulos, C., Papadopoulos, O., Pectasides, D., Mantzourani, M., et al. (2006). Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group. Annals of oncology 17, 1835-1841.

Grivennikov, S.I., Greten, F.R., and Karin, M. (2010). Immunity, inflammation, and cancer. Cell 140, 883-899.

Harris, S.G., Padilla, J., Koumas, L., Ray, D., and Phipps, R.P. (2002). Prostaglandins as modulators of immunity. Trends in immunology 23, 144-150.

Ho, C.M., Huang, C.C., Huang, C.J., Cheng, J.S., Chen, I.S., Tsai, J.Y., Jiann, B.P., Tseng, P.L., Kuo, S.J., and Jan, C.R. (2008). Effects of antrodia camphorata on viability, apoptosis, and [Ca2+]i in PC3 human prostate cancer cells. The Chinese journal of physiology 51, 78-84.

Hseu, Y.-C., Wu, F.-Y., Wu, J.-J., Chen, J.-Y., Chang, W.-H., Lu, F.-J., Lai, Y.-C., and Yang, H.-L. (2005). Anti-inflammatory potential of Antrodia Camphorata through inhibition of iNOS, COX-2 and cytokines via the NF-κB pathway. International immunopharmacology 5, 1914-1925.

Hseu, Y.C., Chen, S.C., Chen, H.C., Liao, J.W., and Yang, H.L. (2008). Antrodia camphorata inhibits proliferation of human breast cancer cells in vitro and in vivo. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 46, 2680-2688.

Hsieh, Y.-C., Rao, Y.K., Whang-Peng, J., Huang, C.-Y.F., Shyue, S.-K., Hsu, S.-L., and Tzeng, Y.-M. (2011). Antcin B and its ester derivative from Antrodia camphorata induce apoptosis in hepatocellular carcinoma cells involves enhancing oxidative stress coincident with activation of intrinsic and extrinsic apoptotic pathway. Journal of Agricultural and Food Chemistry 59, 10943-10954.

Hsu, Y.-L., Kuo, P.-L., Cho, C.-Y., Ni, W.-C., Tzeng, T.-F., Ng, L.-T., Kuo, Y.-H., and Lin, C.-C. (2007). Antrodia cinnamomea fruiting bodies extract suppresses the invasive potential of human liver cancer cell line PLC/PRF/5 through inhibition of nuclear factor κB pathway. Food and Chemical Toxicology 45, 1249-1257.

Hu, J., Chen, C., Su, Y., Du, J., Qian, X., and Jin, Y. (2012). Vascular endothelial growth factor promotes the expression of cyclooxygenase 2 and matrix metalloproteinases in Lewis lung carcinoma cells. Experimental and therapeutic medicine 4, 1045-1050.

Hung-Chen, C., De-Peng, W., Cherng, I.W., and Chuen-Her, U. (1995). A sesquiterpene lactone, phenyl and biphenyl compounds from Antrodia cinnamomea. Phytochemistry 39, 613-616.

Janeway, Paul Travers, Mark Walport, and Shlomchik., M.J. (2005). Immunobiology: the immune system in health and disease (New York: Garland Science).

Joyce, J.A., and Pollard, J.W. (2009). Microenvironmental regulation of metastasis. Nature Review Cancer 9, 239-252.

Kai, H., Kitadai, Y., Kodama, M., Cho, S., Kuroda, T., Ito, M., Tanaka, S., Ohmoto, Y., and Chayama, K. (2005). Involvement of proinflammatory cytokines IL-1beta and IL-6 in progression of human gastric carcinoma. Anticancer research 25, 709-713.

Kalluri, R., and Kalluri (2003). Angiogenesis: Basement membranes: structure, assembly and role in tumour angiogenesis. Nature Reviews Cancer 3, 422-433.

Kaufman, H., and Disis, M. (2004). Immune system versus tumor: shifting the balance in favor of DCs and effective immunity. The Journal of clinical investigation 113, 664-667.

Koga, H., Sakisaka, S., Ohishi, M., Kawaguchi, T., Taniguchi, E., Sasatomi, K., Harada, M., Kusaba, T., Tanaka, M., Kimura, R., et al. (1999). Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology 29, 688-696.

Kryczek, I., Grybos, M., Karabon, L., Klimczak, A., and Lange, A. (2000). IL-6 production in ovarian carcinoma is associated with histiotype and biological characteristics of the tumour and influences local immunity. British journal of cancer 82, 621-628.

Kundu, J.K., and Surh, Y.J. (2008). Inflammation: gearing the journey to cancer. Mutation research 659, 15-30.

Kut, C., Mac Gabhann, F., and Popel, A.S. (2007). Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer. British journal of cancer 97, 978-985.

Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., and Hermoso, M.A. (2014). Chronic inflammation and cytokines in the tumor microenvironment. Journal of Immunology Research 2014, 19.

Levin, V.A., Levin, P., Giglio, V.K., Puduvalli, J., Jochec, M.D., Groves, W.K.A., Yung, K., and Hess (2006). Combination chemotherapy with 13-cis-retinoic acid and celecoxib in the treatment of glioblastoma multiforme. Journal of neuro-oncology 78, 85-90.

Li, B., Cai, Y., Qi, C., Hansen, R., Ding, C., Mitchell, T.C., and Yan, J. (2010). Orally administered particulate beta-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 16, 5153-5164.

Li, C., Yang, C., Zhang, K., Shi, W., Li, J., Li, Y., and Yin, S. (2012). Synthesis and Anti-inflammatory Activity of Novel Benzimidazole (Benzothiazole) Phenylursolate. Chinese Journal of Organic Chemistry 32, 133-137.

Liu, W., Reinmuth, N., Stoeltzing, O., Parikh, A., Tellez, C., Williams, S., Jung, Y., Fan, F., Takeda, A., Akagi, M., et al. (2003). Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways. Cancer research 63, 3632-3636.

Liu, Y.-J., Liu, J., Zhang, P.J.L., Lane, E.Y.T., Chan, I.C.M., and Maclennan (1991). Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. European Journal of Immunology 21, 2951-2962.

Lu, M.-C., Lu, Y.-C., Du, J.-J., Chuu, S.-L., Hwang, P.-C., Hsieh, C.-S., Hung, F.-R., Chang, Y.-C., and Wu (2009). Active extracts of wild fruiting bodies of Antrodia camphorata (EEAC) induce leukemia HL 60 cells apoptosis partially through histone hypoacetylation and synergistically promote anticancer effect of trichostatin A. Archives of toxicology 83, 121-129.

Lu, M.K., Cheng, J.J., Lai, W.L., Lin, Y.R., and Huang, N.K. (2006). Adenosine as an active component of Antrodia cinnamomea that prevents rat PC12 cells from serum deprivation-induced apoptosis through the activation of adenosine A(2A) receptors. Life sciences 79, 252-258.

Mach, N., Gillessen, S., Wilson, S.B., Sheehan, C., Mihm, M., and Dranoff, G. (2000). Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-Ligand. Cancer research 60, 3239-3246.

Mann, J.R., and DuBois, R.N. (2004). Cyclooxygenase-2 and gastrointestinal cancer. Cancer journal (Sudbury, Mass) 10, 145-152.

Mantovani, A., Mantovani, P., Allavena, A., Sica, F., and Balkwill (2008). Cancer-related inflammation. Nature 454, 436-444.

Matsuzaki, K., Matsuzaki, M., Murata, K., Yoshida, G., Sekimoto, Y., Uemura, N., Sakaida, M., Kaibori, Y., Kamiyama, M., Nishizawa, J., et al. (2007). Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor β signaling, promoting cirrhosis and hepatocellular carcinoma. Hepatology 46, 48-57.

McKenzie, R.C., Park, E.S., Brown, W.R., Shivji, G.S., and Sauder, D.N. (1994). Effect of ultraviolet-inducible cytokines on melanoma growth in vivo: stimulation of melanoma growth by interleukin-1 and -6. Photodermatology, Photoimmunology &; Photomedicine 10, 74-79.

Menetrier Caux, C., Montmain, G., Dieu, M.C., Bain, C., Favrot, M.C., Caux, C., and Blay, J.Y. (1998). Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood 92, 4778-4791.

Montesano, R., SouliA&;#402;, P., Eble, J., and Carrozzino, F. (2005). Tumour necrosis factor alpha confers an invasive, transformed phenotype on mammary epithelial cells. Journal of cell science 118, 3487-3500.

Moore, R.J., Owens, D.M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M., et al. (1999). Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nature medicine 5, 828-831.

Moradali, M.F., Mostafavi, H., Ghods, S., and Hedjaroude, G.A. (2007). Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi). International immunopharmacology 7, 701-724.

Mukhopadhyay, D., Mukhopadhyay, L., Tsiokas, X.-M., Zhou, D., Foster, J., Brugge, V., and Sukhatme (1995). Hypoxic induction of human vascular endothelial growth factor expressionthrough c-Src activation. Nature 375, 577-581.

Nakanishi, Y., Nakatsuji, M., Seno, H., Ishizu, S., Akitake-Kawano, R., Kanda, K., Ueo, T., Komekado, H., Kawada, M., Minami, M., et al. (2011). COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin/+ mouse polyps. Carcinogenesis 32, 1333-1339.

Narisawa, T., Takahashi, M., Niwa, M., Fukaura, Y., and Wakizaka, A. (1987). Involvement of prostaglandin E2 in bile acid-caused promotion of colon carcinogenesis and anti-promotion by the cyclooxygenase inhibitor indomethacin. Japanese journal of cancer research 78, 791-798.

Narumiya, S., Sugimoto, Y., and Ushikubi, F. (1999). Prostanoid receptors: structures, properties, and functions. Physiological reviews 79, 1193-1226.

Naylor, M.S., Stamp, G.W., Foulkes, W.D., Eccles, D., and Balkwill, F.R. (1993). Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. The Journal of clinical investigation 91, 2194-2206.

Park, S.-J., Nakagawa, T., Kitamura, H., Atsumi, T., Kamon, H., Sawa, S.-I., Kamimura, D., Ueda, N., Iwakura, Y., Ishihara, K., et al. (2004). IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. The journal of immunology 173, 3844-3854.

Park, W., Oh, Y.T., Han, J.H., and Pyo, H. (2008). Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2. Journal of experimental &; clinical cancer research : CR 27, 66.

Peng, C.-C., Chen, K.-C., Peng, R.Y., Chyau, C.-C., Su, C.-H., and Hsieh-Li, H.M. (2007). Antrodia camphorata extract induces replicative senescence in superficial TCC, and inhibits the absolute migration capability in invasive bladder carcinoma cells. Journal of ethnopharmacology 109, 93-103.

Philpott, M., Philpott, L., and Ferguson (2004). Immunonutrition and cancer. Mutation research - Fundamental and Molecular Mechanisms of Mutagenesis 551, 29-42.

Phipps, R.P., Stein, S.H., and Roper, R.L. (1991). A new view of prostaglandin E regulation of the immune response. Immunology today 12, 349-352.

Pinheiro, R.M., and Calixto, J.B. (2002). Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation. Inflamm res 51, 603-610.

Plat, J. (2005). Food components and immune function. Current opinion in lipidology 16, 31.

Prince, H.M., Mileshkin, L., Roberts, A., Ganju, V., Underhill, C., Catalano, J., Bell, R., Seymour, J., Westerman, D., Simmons, P., et al. (2005). A multicenter phase II trial of thalidomide and celecoxib for patients with relapsed and refractory multiple myeloma. Clinical cancer research 11, 5504-5514.

Rabinovich, G.A., Gabrilovich, D., and Sotomayor, E.M. (2007). Immunosuppressive strategies that are mediated by tumor cells. Annual review of immunology 25, 267-296.

Rao, Y.K., Fang, S.H., and Tzeng, Y.M. (2007). Evaluation of the anti-inflammatory and anti-proliferation tumoral cells activities of Antrodia camphorata, Cordyceps sinensis, and Cinnamomum osmophloeum bark extracts. Journal of ethnopharmacology 114, 78-85.

Rigas, B., Goldman, I.S., and Levine, L. (1993). Altered eicosanoid levels in human colon cancer. The Journal of laboratory and clinical medicine 122, 518-523.

Roitt, I.M., Hutchings, P.R., Dawe, K.I., Sumar, N., Bodman, K.B., and Cooke, A. (1992). The forces driving autoimmune disease. Journal of autoimmunity 5 Suppl A, 11-26.

Rose-John, S., and Schooltink, H. (2007). Cytokines are a therapeutic target for the prevention of inflammation-induced cancers. In cancer prevention, H.-J. Senn, and U. Kapp, eds. (Springer Berlin Heidelberg), pp. 57-66.

Rus, H., Cudrici, C., and Niculescu, F. (2005). The role of the complement system in innate immunity. Immunologic Research 33, 103-112.

Saijo, Y., Tanaka, M., Miki, M., Usui, K., Suzuki, T., Maemondo, M., Hong, X., Tazawa, R., Kikuchi, T., Matsushima, K., et al. (2002). Proinflammatory cytokine IL-1β promotes tumor growth of lewis lung carcinoma by induction of angiogenic factors: In vivo analysis of tumor-stromal interaction. The Journal of Immunology 169, 469-475.

Schmiegel, W., Roeder, C., Schmielau, J., Rodeck, U., and Kalthoff, H. (1993). Tumor necrosis factor alpha induces the expression of transforming growth factor alpha and the epidermal growth factor receptor in human pancreatic cancer cells. Proceedings of the National Academy of Sciences of the United States of America 90, 863-867.

Schneider, M.R., Hoeflich, A., Fischer, J.R., Wolf, E., Sordat, B., and Lahm, H. (2000). Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. Cancer Lett 151, 31-38.

Schottenfeld, D., Schottenfeld, J., and Beebe, D. (2006). Chronic inflammation: A common and important factor in the pathogenesis of neoplasia. Ca 56, 69-83.

Senger, D.R., Galli, S.J., Dvorak, A.M., Perruzzi, C.A., Harvey, V.S., and Dvorak, H.F. (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (New York, NY) 219, 983-985.

Shen, Y.C., Yang, S.W., Lin, C.S., Chen, C.H., Kuo, Y.H., and Chen, C.F. (1997). Zhankuic acid F: a new metabolite from a formosan fungus Antrodia cinnamomea. Planta medica 63, 86-88.

Singh, A.K. (2011). COX-2 as a serum marker and therapeutic agent for cancer. Journal of Natural Science Biology and Medicine 2, 142.

Sonoshita, M., Takaku, K., Sasaki, N., Sugimoto, Y., Ushikubi, F., Narumiya, S., Oshima, M., and Taketo, M.M. (2001). Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice. Nature medicine 7, 1048-1051.

Sporn, M.B. (1996). The war on cancer. Lancet 347, 1377-1381.

Stanley, G., Harvey, K., Slivova, V., Jiang, J., and Sliva, D. (2005). Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells. Biochemical and biophysical research communications 330, 46-52.

Stifter, G., Stifter, S., Heiss, G., Gastl, A., Tzankov, R., and Stauder (2005). Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis. European journal of haematology 75, 485-491.

Surh, Y.-J., Surh, K.-S., Chun, H.-H., Cha, S., Han, Y.-S., Keum, K.-K., Park, S., and Lee (2001). Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutation research - Fundamental and Molecular Mechanisms of Mutagenesis 480, 243-268.

Tjiu, J.-S., Chen, C.-T., Shun, S.-J., Lin, Y.-H., Liao, C.-Y., Chu, T.-F., Tsai, H.-C., Chiu, Y.-S., Dai, H., Inoue, P.-C., et al. (2009). Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction. Journal of investigative dermatology 129, 1016-1025.

Toomey, D.P., Murphy, J.F., and Conlon, K.C. (2009). COX-2, VEGF and tumour angiogenesis. The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland 7, 174-180.

Toyota, M., Shen, L., Ohe Toyota, M., Hamilton, S.R., Sinicrope, F.A., and Issa, J.P. (2000). Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors. Cancer research 60, 4044-4048.

Trikha, M., Corringham, R., Klein, B., and Rossi, J.-F.o. (2003). Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence. Clinical cancer research 9, 4653-4665.

Tsujii, M., Kawano, S., and DuBois, R.N. (1997). Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proceedings of the National Academy of Sciences of the United States of America 94, 3336-3340.

Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., and DuBois, R.N. (1998). Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93, 705-716.

Tucker, O.N., Dannenberg, A.J., Yang, E.K., Zhang, F., Teng, L., Daly, J.M., Soslow, R.A., Masferrer, J.L., Woerner, B.M., Koki, A.T., et al. (1999). Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer research 59, 987-990.

Vanderveen, E., and Vanderveen (1986). Arachidonic acid metabolites in cutaneous carcinomas. Archives of dermatology 122, 407.

Wang, J., Wakeham, J., Harkness, R., and Xing, Z. (1999). Macrophages are a significant source of type 1 cytokines during mycobacterial infection. The Journal of clinical investigation 103, 1023-1029.

Wasser, S. (2002). Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Applied Microbiology and Biotechnology 60, 258-274.

Wasser, S. (2011). Current findings, future trends, and unsolved problems in studies of medicinal mushrooms. Applied Microbiolgy and Biotechnology 89, 1323-1332.

Wasser, S.P., and Weis, A.L. (1999). Medicinal Properties of Substances Occurring in Higher Basidiomycetes Mushrooms: Current Perspectives (Review). 1, 31-62.

Weinreb, M., Machwate, M., Shir, N., Abramovitz, M., Rodan, G.A., and Harada, S. (2001). Expression of the prostaglandin E(2) (PGE(2)) receptor subtype EP(4) and its regulation by PGE(2) in osteoblastic cell lines and adult rat bone tissue. Bone 28, 275-281.

Williams, C.S., Tsujii, M., Reese, J., Dey, S.K., and DuBois, R.N. (2000). Host cyclooxygenase-2 modulates carcinoma growth. The Journal of clinical investigation 105, 1589-1594.

Wirth, L., Haddad, R., Lindeman, N., Zhao, X., Lee, J., Joshi, V., Norris, C., and Posner, M. (2005). Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck. Journal of clinical oncology 23, 6976-6981.

Wolff, H., Saukkonen, K., Anttila, S., Karjalainen, A., Vainio, H., and Ristimaki, A. (1998). Expression of cyclooxygenase-2 in human lung carcinoma. Cancer research 58, 4997-5001.

Wu, D.-P., and Chiang, H.-C. (1995). Constituents of Antrodia cinnamomea. Journal of the Chinese Chemical Society 42, 797-800.

Wu, H., Pan, C.L., Yao, Y.C., Chang, S.S., Li, S.L., and Wu, T.F. (2006). Proteomic analysis of the effect of Antrodia camphorata extract on human lung cancer A549 cell. Proteomics 6, 826-835.

Wu, M.T., Tzang, B.S., Chang, Y.Y., Chiu, C.H., Kang, W.Y., Huang, C.H., Chen, Y.C. (2011). Effects of Antrodia camphorata on alcohol clearance and antifibrosis in livers of rats continuously fed alcohol. Journal of Agricultural and Food Chemistry 59, 4278-4254.

Wu, S.H., Ryvarden, L., and Chang, T.T. (1997). Antrodia camphorata (" niu-chang-chih"), new combination of a medicinal fungus in Taiwan. Botanical Bulletin of Academia Sinica 38, 273.

Yang, H.L., Chen, C.S., Chang, W.H., Lu, F.J., Lai, Y.C., Chen, C.C., Hseu, T.H., Kuo, C.T., and Hseu, Y.C. (2006). Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by Antrodia camphorata. Cancer Lett 231, 215-227.

Yang, H.L., Kuo, Y.H., Tsai, C.T., Huang, Y.T., Chen, S.C., Chang, H.W., Lin, E., Lin, W.H., and Hseu, Y.C. (2011). Anti-metastatic activities of Antrodia camphorata against human breast cancer cells mediated through suppression of the MAPK signaling pathway. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 49, 290-298.

Yeh, C.-T., Rao, Y.K., Yao, C.-J., Yeh, C.-F., Li, C.-H., Chuang, S.-E., Luong, J.H.T., Lai, G.-M., and Tzeng, Y.-M. (2009). Cytotoxic triterpenes from Antrodia camphorata and their mode of action in HT-29 human colon cancer cells. Cancer Letters 285, 73-79.

Zhang, P., and Cheung, P.C. (2002). Evaluation of sulfated Lentinus edodes alpha-(1-->3)-D-glucan as a potential antitumor agent. Bioscience, biotechnology, and biochemistry 66, 1052-1056.

Zhang, Y., Ning, Z., Lu, C., Zhao, S., Wang, J., Liu, B., Xu, X., and Liu, Y. (2013). Triterpenoid resinous metabolites from the genus Boswellia: pharmacological activities and potential species-identifying properties. Chemistry Central Journal 7, 153.

Zou, W., and Zou (2005). Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nature Reviews Cancer 5, 263-274.



QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top